Trends in the use of local intervention for metastatic hormone-naïve prostate cancer: A multicenter retrospective study.
Ryuma TanakaShingo HatakeyamaShintaro NaritaToshihiko SakuraiToshikazu TanakaHikari MiuraTakuya OishiSadafumi KawamuraSenji HoshiShigeto IshidoyaKoji MitsuzukaAkihiro ItoNorihiko TsuchiyaTomonori HabuchiChikara OhyamaPublished in: International journal of urology : official journal of the Japanese Urological Association (2023)
The use of local intervention in combination with upfront therapy to treat mHNPC increased for the duration of our study regardless of the tumor burden. Local intervention in addition to the standard of care for mHNPC may be a feasible treatment option for selected patients, taking into consideration the duration of and response to initial treatment.
Keyphrases
- prostate cancer
- randomized controlled trial
- end stage renal disease
- healthcare
- small cell lung cancer
- newly diagnosed
- squamous cell carcinoma
- ejection fraction
- chronic kidney disease
- palliative care
- clinical trial
- prognostic factors
- radical prostatectomy
- cross sectional
- pain management
- bone marrow
- patient reported outcomes
- replacement therapy